While the binding of the mAb to AXL+ AML cell lines resulted in a weak signal (Figure 2D-E), the MFI of the total population shifted significantly with sdAb20 compared to the control sdAb (R3B23) in AXL+ AML cells (Figure 2F-G). The gene discussed is AXL; the disease is acute myeloid leukemia.